Pricing & Reimbursement

 

Pricing & Reimbursement, Wednesday 24 April 2024

Marshall Summar
Pricing & Reimbursement
11:25

Strategies to save time and cost in rare disease drug development

Marshall Summar, Chief Executive Officer, Uncommon Cures
Pricing & Reimbursement
11:45

Sponsored Red Nucleus

Sponsored Red Nucleus

Panel discussion
Pricing & Reimbursement
12:05

Pricing, reimbursement and payer challenges for rare diseases in the US

Kristin Viswanathan Wolff, Senior Director, Global Government Affairs And Public Policy, bluebird bio
Jaclyn Martin, Vice President of Global Head Market Access Cell and Gene Therapy, Bayer
Durhane Wong-Rieger, President, Chief Executive Officer & Chair, Canadian Organisation for Rare Diseases & Rare Diseases International
Alexander Natz
Pricing & Reimbursement
15:00

Pricing challenges for rare diseases in Europe

Alexander Natz, Director General, EUCOPE - European Confederation of Pharmaceutical Entrepreneurs
Jin Ding
Pricing & Reimbursement
15:40

Title to be announced

Panel discussion
Pricing & Reimbursement
16:00

Cell and gene therapy access and reimbursement challenges in Europe

Moderator: Alexander Natz, Director General, EUCOPE - European Confederation of Pharmaceutical Entrepreneurs
Jon Weber, Senior Director of Cell & Gene Therapies Access, Bayer
Sheela Upadhyaya, Life Science Advisor in Rare Diseases & Special Advisor, Fipra International
last published: 27/Mar/24 15:36

 

 

Get Involved At World Orphan Drug Congress USA

 

To Sponsor Or Exhibit

 
 

Justin Franks
justin.franks@terrapinn.com
t/ +1 914 819 3506

 

 

 

To Speak

 
 

Gina McHugh
gina.mchugh@terrapinn.com
t/ +1 646 619 1775

 

 

 

Marketing & Press Opportunities

 
 

Kaylie Brogan
kaylie.brogan@terrapinn.com